IBDEI0US ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13708,1,4,0)
 ;;=4^E11.3412
 ;;^UTILITY(U,$J,358.3,13708,2)
 ;;=^5138348
 ;;^UTILITY(U,$J,358.3,13709,0)
 ;;=E11.3413^^83^815^45
 ;;^UTILITY(U,$J,358.3,13709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13709,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Bilaterral
 ;;^UTILITY(U,$J,358.3,13709,1,4,0)
 ;;=4^E11.3413
 ;;^UTILITY(U,$J,358.3,13709,2)
 ;;=^5138349
 ;;^UTILITY(U,$J,358.3,13710,0)
 ;;=E11.3491^^83^815^46
 ;;^UTILITY(U,$J,358.3,13710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13710,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,13710,1,4,0)
 ;;=4^E11.3491
 ;;^UTILITY(U,$J,358.3,13710,2)
 ;;=^5138351
 ;;^UTILITY(U,$J,358.3,13711,0)
 ;;=E11.3492^^83^815^47
 ;;^UTILITY(U,$J,358.3,13711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13711,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,13711,1,4,0)
 ;;=4^E11.3492
 ;;^UTILITY(U,$J,358.3,13711,2)
 ;;=^5138352
 ;;^UTILITY(U,$J,358.3,13712,0)
 ;;=E11.3493^^83^815^48
 ;;^UTILITY(U,$J,358.3,13712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13712,1,3,0)
 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Bilateral
 ;;^UTILITY(U,$J,358.3,13712,1,4,0)
 ;;=4^E11.3493
 ;;^UTILITY(U,$J,358.3,13712,2)
 ;;=^5138353
 ;;^UTILITY(U,$J,358.3,13713,0)
 ;;=E11.3511^^83^815^37
 ;;^UTILITY(U,$J,358.3,13713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13713,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,13713,1,4,0)
 ;;=4^E11.3511
 ;;^UTILITY(U,$J,358.3,13713,2)
 ;;=^5138355
 ;;^UTILITY(U,$J,358.3,13714,0)
 ;;=E11.3512^^83^815^38
 ;;^UTILITY(U,$J,358.3,13714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13714,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Left Eye
 ;;^UTILITY(U,$J,358.3,13714,1,4,0)
 ;;=4^E11.3512
 ;;^UTILITY(U,$J,358.3,13714,2)
 ;;=^5138356
 ;;^UTILITY(U,$J,358.3,13715,0)
 ;;=E11.3513^^83^815^39
 ;;^UTILITY(U,$J,358.3,13715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13715,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Bilateral
 ;;^UTILITY(U,$J,358.3,13715,1,4,0)
 ;;=4^E11.3513
 ;;^UTILITY(U,$J,358.3,13715,2)
 ;;=^5138357
 ;;^UTILITY(U,$J,358.3,13716,0)
 ;;=E11.3551^^83^815^50
 ;;^UTILITY(U,$J,358.3,13716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13716,1,3,0)
 ;;=3^Diabetes Type 2 w/ Stable Prolif Rtnop,Right Eye
 ;;^UTILITY(U,$J,358.3,13716,1,4,0)
 ;;=4^E11.3551
 ;;^UTILITY(U,$J,358.3,13716,2)
 ;;=^5138371
 ;;^UTILITY(U,$J,358.3,13717,0)
 ;;=E11.3552^^83^815^51
 ;;^UTILITY(U,$J,358.3,13717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13717,1,3,0)
 ;;=3^Diabetes Type 2 w/ Stable Prolif Rtnop,Left Eye
 ;;^UTILITY(U,$J,358.3,13717,1,4,0)
 ;;=4^E11.3552
 ;;^UTILITY(U,$J,358.3,13717,2)
 ;;=^5138372
 ;;^UTILITY(U,$J,358.3,13718,0)
 ;;=E11.3553^^83^815^52
 ;;^UTILITY(U,$J,358.3,13718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13718,1,3,0)
 ;;=3^Diabetes Type 2 w/ Stable Prolif Rtnop,Bilateral
 ;;^UTILITY(U,$J,358.3,13718,1,4,0)
 ;;=4^E11.3553
 ;;^UTILITY(U,$J,358.3,13718,2)
 ;;=^5138373
 ;;^UTILITY(U,$J,358.3,13719,0)
 ;;=E11.3591^^83^815^40
 ;;^UTILITY(U,$J,358.3,13719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13719,1,3,0)
 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/o Macular Edema,Right Eye
 ;;^UTILITY(U,$J,358.3,13719,1,4,0)
 ;;=4^E11.3591
